CPI MP writes to PM to reduce price of life-saving drugs

Image
ANI General News
Last Updated : Dec 15 2019 | 8:30 PM IST

Communist Party of India (CPI) MP, Binoy Viswam on Sunday wrote to Prime Minister Narendra Modi requesting him to withdraw the decision of the National Pharmaceutical Pricing Authority increasing the ceiling price of essential life-saving drugs.

In the letter addressed to Prime Minister Modi, Viswam said, "On behalf of the common people in India, I request you to take immediate steps to withdraw the decision of the National Pharmaceutical Pricing Authority to increase the ceiling price of essential lifesaving drugs."

"Though the government claims that this move is in public interest, the people apprehend that these steps would lead to a further financial burden on the common masses," he said.

"While you have repeatedly made a call for "Ayushman Bharat", the reality is that even today the burden of health care is a cause of great indebtedness to millions of people across the country," the Rajya Sabha MP said in the letter.

"To increase the price of essential life-saving medicines is only going to make this worse. This decision is a direct attack on the common citizen of this country while serving the interests of large corporations. Given the clear ramifications of this move, I urge you to withdraw this decision and explore alternative solutions in securing the availability of affordable essential life-saving medicines," he added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 15 2019 | 8:18 PM IST

Next Story